EP. 1: Dr. Rhee on the Benefit of Zanubrutinib Vs Ibrutinib in R/R CLL
February 8th 2023June-Wha Rhee, MD, discusses the benefit of zanubrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia, as well as the incidence of cardiac disorders associated with the BTK inhibitors.